Genestra HMF Intensive 50 30 Veggie Caps

HMF Intensive 50

Allergen Free Formula
Vegan
Free From Gluten
Free From GMO
Free From FOS
Free From Starch
Free From Yeast
Free From Corn
Free From Soy
Free From Sodium
Free From Sugar
Free From Artificial Colouring Or Flavouring
Free From Dairy Or Animal Products

Delayed-release, shelf-stable probiotic formula

Supports gastrointestinal health
Provides 50 billion CFU per dose from a combination of four proprietary strains
Formulated with acid-resistant and delayed-release capsules for targeted delivery to the intestines
Convenient, once-daily capsule format

HMF Intensive 50 is a shelf-stable probiotic formula that offers 50 billion CFU from a combination of four proprietary strains. These microorganisms have been used in a wide body of clinical research and are one of the most studied probiotic combinations worldwide.1-6 Research has demonstrated that these strains support a healthy gut flora and promote gastrointestinal comfort.1-4 In addition, these human-sourced strains were selected based on their high quality and viability, strong epithelial adherence, and naturally high tolerance to stomach and bile acid.7 To further enhance probiotic survivability through the stomach, HMF Intensive 50 is produced with delayed release capsules. Each capsule is formulated with unique polymer properties that resist stomach acid and delay the release of probiotics after swallowing, allowing for complete, targeted release in the intestines and optimal probiotic activity.8
References1. Madden, JA, Plummer, SF, Tang, J, Garaiova, I, Plummer, NT, Herbison, M, Hunter, JO, Shimada, T, Cheng, L, Shirakawa, T. Int Immunopharmacol. 2005; 5(6): 1091-1097.2. Plummer, SF, Garaiova, I, Sarvotham, T, Cottrell, SL, Le Scouiller, S, Weaver, MA, Tang, J, Dee, P, Hunter, J. Int J Antimicrob Agents. 2005; 26(1): 69-74.3. Plummer, S, Weaver, MA, Harris, JC, Dee, P, Hunter, J. Int Microbiol. 2004; 7(1): 59-62.4. Williams, EA, Stimpson, J, Wang, D, Plummer, S, Garaiova, I, Barker, ME, Corfe, BM. Aliment Pharmacol Ther. 2009; 29(1): 97-103.5. Garaiova, I, Muchová, J, Nagyová, Z, Wang, D, Li, JV, Országhová, Z, Michael, DR, Plummer, SF, Ďuračková, Z. Eur J Clin Nutr. 2015; 69(3): 373-379.6. Allen, SJ, Jordan, S, Storey, M, Thornton, CA, Gravenor, M, Garaiova, I, Plummer, SF, Wang, D, Morgan, G. J Nutr. 2010; 140(3): 483-488.7. Seroyal. Data on file.8. Amo, R. Capsugel®. (2014). DRcaps® Capsules Achieve Delayed Release Properties for Nutritional Ingredients in Human Clinical Study. [White Paper].